BACE1 and ovarian cancer: Elevation of lncRNA BACE1-AS was a potential mechanism to inhibit the proliferation and invasion of human ovarian cancer stem cells and may be a novel target of anisomycin in the treatment of ovarian cancer (Chen et al., 2016).